Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023352571> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2023352571 endingPage "87" @default.
- W2023352571 startingPage "83" @default.
- W2023352571 abstract "Previous studies have investigated toxicity inhibition of optically active compounds by potentized preparations of their enantiomers. It was hypothesised that inhibition of toxicity may be stereospecific. This paper presents 2 studies investigating stereoisomer potencies in terms of their ability to counteract toxicity of the (-) stereoisomer. The stereoisomers used were (-)-trans-(1S,2S)-U-50488 HCl and (+)-trans-(1R,2R)-U-50488 HCl.Designs were prospective, blind, randomised, intention-to-treat and compared the efficacy of 2 indistinguishable treatments. The outcome was the difference in survival. Potency 'chords' consisting of 4th, 12th and 30th approximately centesimal dilutions were prepared, representing concentrations of 1.08 x 10(-10) M. One study compared inhibition of (-)-U-50488 toxicity injected ip at the estimated LD50 into male ICR mice, treated with a potency chord of the same stereoisomer, with control ('isopathic' study). The other study compared inhibition of toxicity by potency chords made from the stereoisomers (+)-U-50488 and (-)-U-50488 ('enantiomer' study), Treatments were administered orally on 11 occasions: twice before and nine times after ip injections.The isopathic study did not yield a significant result. In the enantiomer study, comparison of isopathy with enantiomer potency treatment showed a highly significant difference odds ratio 1.97 (95% CI: 1.23-3.14).We conclude that enantiomeric potencies are superior to identically produced isopathic potencies, in inhibiting toxicity of (-)-U-50488 HCl. Homeopathic inhibition of toxicity may be stereospecific." @default.
- W2023352571 created "2016-06-24" @default.
- W2023352571 creator A5031656058 @default.
- W2023352571 creator A5041518597 @default.
- W2023352571 creator A5072571007 @default.
- W2023352571 date "2009-04-01" @default.
- W2023352571 modified "2023-09-25" @default.
- W2023352571 title "Isopathic versus enantiomeric inhibition of U-50488 HCl toxicity – experimental studies" @default.
- W2023352571 cites W1575203748 @default.
- W2023352571 cites W1964332593 @default.
- W2023352571 cites W1994051559 @default.
- W2023352571 cites W1998375287 @default.
- W2023352571 cites W2010613996 @default.
- W2023352571 cites W2010675706 @default.
- W2023352571 cites W2010676949 @default.
- W2023352571 cites W2025066186 @default.
- W2023352571 cites W2039166242 @default.
- W2023352571 cites W2046457461 @default.
- W2023352571 cites W2059824649 @default.
- W2023352571 cites W2061481788 @default.
- W2023352571 cites W2064328524 @default.
- W2023352571 cites W2149566704 @default.
- W2023352571 cites W2171788374 @default.
- W2023352571 cites W2214114766 @default.
- W2023352571 doi "https://doi.org/10.1016/j.homp.2009.02.002" @default.
- W2023352571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19358960" @default.
- W2023352571 hasPublicationYear "2009" @default.
- W2023352571 type Work @default.
- W2023352571 sameAs 2023352571 @default.
- W2023352571 citedByCount "1" @default.
- W2023352571 countsByYear W20233525712012 @default.
- W2023352571 crossrefType "journal-article" @default.
- W2023352571 hasAuthorship W2023352571A5031656058 @default.
- W2023352571 hasAuthorship W2023352571A5041518597 @default.
- W2023352571 hasAuthorship W2023352571A5072571007 @default.
- W2023352571 hasConcept C161790260 @default.
- W2023352571 hasConcept C178790620 @default.
- W2023352571 hasConcept C185592680 @default.
- W2023352571 hasConcept C187921627 @default.
- W2023352571 hasConcept C202751555 @default.
- W2023352571 hasConcept C29730261 @default.
- W2023352571 hasConcept C486523 @default.
- W2023352571 hasConcept C55493867 @default.
- W2023352571 hasConcept C57992300 @default.
- W2023352571 hasConcept C71240020 @default.
- W2023352571 hasConcept C71924100 @default.
- W2023352571 hasConcept C98274493 @default.
- W2023352571 hasConceptScore W2023352571C161790260 @default.
- W2023352571 hasConceptScore W2023352571C178790620 @default.
- W2023352571 hasConceptScore W2023352571C185592680 @default.
- W2023352571 hasConceptScore W2023352571C187921627 @default.
- W2023352571 hasConceptScore W2023352571C202751555 @default.
- W2023352571 hasConceptScore W2023352571C29730261 @default.
- W2023352571 hasConceptScore W2023352571C486523 @default.
- W2023352571 hasConceptScore W2023352571C55493867 @default.
- W2023352571 hasConceptScore W2023352571C57992300 @default.
- W2023352571 hasConceptScore W2023352571C71240020 @default.
- W2023352571 hasConceptScore W2023352571C71924100 @default.
- W2023352571 hasConceptScore W2023352571C98274493 @default.
- W2023352571 hasIssue "2" @default.
- W2023352571 hasLocation W20233525711 @default.
- W2023352571 hasLocation W20233525712 @default.
- W2023352571 hasOpenAccess W2023352571 @default.
- W2023352571 hasPrimaryLocation W20233525711 @default.
- W2023352571 hasRelatedWork W2025536095 @default.
- W2023352571 hasRelatedWork W2041582460 @default.
- W2023352571 hasRelatedWork W2047121540 @default.
- W2023352571 hasRelatedWork W2058366260 @default.
- W2023352571 hasRelatedWork W2104811164 @default.
- W2023352571 hasRelatedWork W2133425930 @default.
- W2023352571 hasRelatedWork W2291507695 @default.
- W2023352571 hasRelatedWork W2953000104 @default.
- W2023352571 hasRelatedWork W3177519816 @default.
- W2023352571 hasRelatedWork W321487358 @default.
- W2023352571 hasVolume "98" @default.
- W2023352571 isParatext "false" @default.
- W2023352571 isRetracted "false" @default.
- W2023352571 magId "2023352571" @default.
- W2023352571 workType "article" @default.